Learn how K2B Therapeutics transitioned from the traditional incubator model to Labshares. The team was fully operational in less than 2 weeks, and now has the flexibility and support to continue growing.

Labshares appoints a Devon Lagasse as VP of Growth and promotes Emma Orfanos to Manager of Business Development, strengthening its leadership as the Greater Boston shared lab provider expands.

Explore what the biotech rebound means for emerging companies, from renewed investment and pharma partnerships to disciplined growth, flexible lab infrastructure, and capital-efficient operations.